|
2025-06-17 |
2025-06-13 |
PS
Planned sale
|
Bhanji Muna
Non-Executive Director
|
1,000
-13.3%
26.67
USD 122,367
|
1,000
-13.3%
|
26.67
|
USD 100,000
|
|
|
2025-06-17 |
2025-06-13 |
PS
Planned sale
|
EASTHAM KARIN
Non-Executive Director
|
1,000
-24.8%
26.66
USD 122,388
|
1,000
-24.8%
|
26.66
|
USD 100,000
|
|
|
2025-06-06 |
2025-06-04 |
PS
Planned sale
|
Leite John
Chief Commercial Officer-CLIA
Officer
|
1,000
-2.9%
27.20
USD 76,410
|
1,000
-2.9%
|
27.20
|
USD 100,000
|
|
|
2025-03-10 |
2025-03-07 |
PS
Planned sale
|
Leite John
Chief Commercial Officer-CLIA
Officer
|
5,011
-4.8%
31.96
USD 160,146
|
5,011
-4.8%
|
31.96
|
USD 160,146
|
|
|
2025-03-10 |
2025-03-07 |
PS
Planned sale
|
Leite John
Chief Commercial Officer-CLIA
Officer
|
2,400
-2.2%
31.04
USD 74,484
|
2,400
-2.2%
|
31.04
|
USD 74,484
|
|
|
2025-03-06 |
2025-03-04 |
PS
Planned sale
|
McGuire Annie
SVP, General Counsel
Officer
|
1,142
-1.6%
33.69
USD 38,476
|
1,142
-1.6%
|
33.69
|
USD 38,476
|
|
|
2025-03-06 |
2025-03-04 |
PS
Planned sale
|
Febbo Phillip G.
Chief Scientific & Med Officer
Officer
|
3,570
-4.1%
33.95
USD 121,205
|
3,570
-4.1%
|
33.95
|
USD 121,205
|
|
|
2025-03-06 |
2025-03-04 |
PS
Planned sale
|
Febbo Phillip G.
Chief Scientific & Med Officer
Officer
|
4,467
-4.9%
32.86
USD 146,808
|
4,467
-4.9%
|
32.86
|
USD 146,808
|
|
|
2025-03-06 |
2025-03-04 |
PS
Planned sale
|
Stapley Marc
Chief Executive Officer
Executive Director
|
1,094
-0.4%
34.37
USD 37,599
|
1,094
-0.4%
|
34.37
|
USD 37,599
|
|
|
2025-03-06 |
2025-03-04 |
PS
Planned sale
|
Stapley Marc
Chief Executive Officer
Executive Director
|
23,414
-8.0%
33.91
USD 794,009
|
23,414
-8.0%
|
33.91
|
USD 794,009
|
|
|
2025-03-06 |
2025-03-04 |
PS
Planned sale
|
Stapley Marc
Chief Executive Officer
Executive Director
|
28,189
-8.8%
32.82
USD 925,248
|
28,189
-8.8%
|
32.82
|
USD 925,248
|
|
|
2025-03-03 |
2025-02-27 |
S
Sale
|
Leite John
Chief Commercial Officer-CLIA
Officer
|
5,746
-6.8%
33.84
USD 194,445
|
5,746
-6.8%
|
33.84
|
USD 194,445
|
|
|
2025-02-05 |
2025-02-03 |
PS
Planned sale
|
Chambers Rebecca
Chief Financial Officer
Officer
|
527
-0.5%
43.85
USD 23,109
|
527
-0.5%
|
43.85
|
USD 23,109
|
|
|
2025-01-06 |
2025-01-02 |
PS
Planned sale
|
EASTHAM KARIN
Non-Executive Director
|
4,691
-20.2%
40.50
USD 189,996
|
4,691
-20.2%
|
40.50
|
USD 189,996
|
|
|
2025-01-06 |
2025-01-02 |
PS
Planned sale
|
EASTHAM KARIN
Non-Executive Director
|
5,309
-18.6%
40.12
USD 213,010
|
5,309
-18.6%
|
40.12
|
USD 213,010
|
|
|
2024-12-17 |
2024-12-13 |
PS
Planned sale
|
Stapley Marc
Chief Executive Officer
Executive Director
|
400
-0.1%
44.14
USD 17,657
|
400
-0.1%
|
44.14
|
USD 17,657
|
|
|
2024-12-17 |
2024-12-13 |
PS
Planned sale
|
Stapley Marc
Chief Executive Officer
Executive Director
|
5,190
-1.7%
43.37
USD 225,080
|
5,190
-1.7%
|
43.37
|
USD 225,080
|
|
|
2024-12-06 |
2024-12-04 |
PS
Planned sale
|
McGuire Annie
SVP, General Counsel
Officer
|
18,699
-20.4%
44.02
USD 823,179
|
18,699
-20.4%
|
44.02
|
USD 823,179
|
|
|
2024-12-06 |
2024-12-04 |
PS
Planned sale
|
Febbo Phillip G.
Chief Scientific & Med Officer
Officer
|
3,934
-4.6%
44.09
USD 173,447
|
3,934
-4.6%
|
44.09
|
USD 173,447
|
|
|
2024-12-04 |
2024-12-03 |
PS
Planned sale
|
Leite John
Chief Commercial Officer-CLIA
Officer
|
1,050
-1.4%
43.25
USD 45,408
|
1,050
-1.4%
|
43.25
|
USD 45,408
|
|
